*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| G130 - Paraneoplastic neuromyopathy and neuropathy - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 16.43 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 181: RESPIRATORY NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 074: CRANIAL AND PERIPHERAL NERVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 57,175 | ||||
| Total Hospitalizations with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 46 | ||||
| DRG Share of Total Hospitalizations | 0.17 | ||||
| % of Total ICD G130 - Paraneoplastic neuromyopathy and neuropathy in DRG | 4.63 | ||||
| Avg LOS at DRG | 6.45 | ||||
| Avg LOS with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 12.37 | ||||
| Readmission Rate at DRG | 26.69 | ||||
| Readmission Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 30.0 | ||||
| Unplanned Readmission Rate at DRG | 20.8 | ||||
| Unplanned Readmission Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 27.5 | ||||
| Total Medicare payments at DRG | $651,389,136 | ||||
| Total Medicare payments with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $773,792 | ||||
| Total Medicare payment per Day at DRG | $1,767 | ||||
| Total Medicare payment per Day with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $1,360 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,393 | ||||
| Total Medicare payment per Hospitalization with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $16,822 | ||||
| Total Medicare Charges at DRG | $3,285,887,644 | ||||
| Total Medicare Charges with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $4,551,561 | ||||
| Avg Charges at DRG | $57,471 | ||||
| Avg Charges with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $98,947 | ||||
| Mortality Rate at DRG | 12.27 | ||||
| Mortality Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA | ||||
| SNF Discharge Rate at DRG | 12.94 | ||||
| SNF Discharge Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 26.09 | ||||
| Home Discharge Rate at DRG | 28.03 | ||||
| Home Discharge Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 32.61 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 092: OTHER DISORDERS OF NERVOUS SYSTEM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 055: NERVOUS SYSTEM NEOPLASMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 844: OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 122,730 | ||||
| Total Hospitalizations with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 18 | ||||
| DRG Share of Total Hospitalizations | 0.37 | ||||
| % of Total ICD G130 - Paraneoplastic neuromyopathy and neuropathy in DRG | 1.81 | ||||
| Avg LOS at DRG | 7.61 | ||||
| Avg LOS with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 8.78 | ||||
| Readmission Rate at DRG | 21.31 | ||||
| Readmission Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA | ||||
| Unplanned Readmission Rate at DRG | 14.13 | ||||
| Unplanned Readmission Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA | ||||
| Total Medicare payments at DRG | $1,397,885,220 | ||||
| Total Medicare payments with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $245,346 | ||||
| Total Medicare payment per Day at DRG | $1,497 | ||||
| Total Medicare payment per Day with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $1,553 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,390 | ||||
| Total Medicare payment per Hospitalization with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $13,630 | ||||
| Total Medicare Charges at DRG | $4,175,290,309 | ||||
| Total Medicare Charges with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $638,570 | ||||
| Avg Charges at DRG | $34,020 | ||||
| Avg Charges with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $35,476 | ||||
| Mortality Rate at DRG | 0.28 | ||||
| Mortality Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA | ||||
| SNF Discharge Rate at DRG | 21.64 | ||||
| SNF Discharge Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA | ||||
| Home Discharge Rate at DRG | 28.06 | ||||
| Home Discharge Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 841: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH COMPLICATION OR COMORBIDITY (CC) | DRG 091: OTHER DISORDERS OF NERVOUS SYSTEM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 25,646 | ||||
| Total Hospitalizations with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 14 | ||||
| DRG Share of Total Hospitalizations | 0.08 | ||||
| % of Total ICD G130 - Paraneoplastic neuromyopathy and neuropathy in DRG | 1.41 | ||||
| Avg LOS at DRG | 5.67 | ||||
| Avg LOS with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 8.43 | ||||
| Readmission Rate at DRG | 36.28 | ||||
| Readmission Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA | ||||
| Unplanned Readmission Rate at DRG | 22.95 | ||||
| Unplanned Readmission Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA | ||||
| Total Medicare payments at DRG | $299,718,477 | ||||
| Total Medicare payments with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $202,940 | ||||
| Total Medicare payment per Day at DRG | $2,062 | ||||
| Total Medicare payment per Day with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $1,720 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,687 | ||||
| Total Medicare payment per Hospitalization with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $14,496 | ||||
| Total Medicare Charges at DRG | $1,432,739,779 | ||||
| Total Medicare Charges with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $968,641 | ||||
| Avg Charges at DRG | $55,866 | ||||
| Avg Charges with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $69,189 | ||||
| Mortality Rate at DRG | 2.6 | ||||
| Mortality Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA | ||||
| SNF Discharge Rate at DRG | 13.23 | ||||
| SNF Discharge Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA | ||||
| Home Discharge Rate at DRG | 49.84 | ||||
| Home Discharge Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|
| Total Hospitalizations at DRG | 231,812 |
| Total Hospitalizations with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 12 |
| DRG Share of Total Hospitalizations | 0.71 |
| % of Total ICD G130 - Paraneoplastic neuromyopathy and neuropathy in DRG | 1.21 |
| Avg LOS at DRG | 4.41 |
| Avg LOS with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | 7.58 |
| Readmission Rate at DRG | 29.12 |
| Readmission Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA |
| Unplanned Readmission Rate at DRG | 22.82 |
| Unplanned Readmission Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA |
| Total Medicare payments at DRG | $1,743,376,418 |
| Total Medicare payments with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $130,256 |
| Total Medicare payment per Day at DRG | $1,704 |
| Total Medicare payment per Day with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $1,431 |
| Total Medicare payment per Hospitalization at DRG | $7,521 |
| Total Medicare payment per Hospitalization with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $10,855 |
| Total Medicare Charges at DRG | $8,543,867,896 |
| Total Medicare Charges with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $741,553 |
| Avg Charges at DRG | $36,857 |
| Avg Charges with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | $61,796 |
| Mortality Rate at DRG | 2.89 |
| Mortality Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA |
| SNF Discharge Rate at DRG | 22.92 |
| SNF Discharge Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA |
| Home Discharge Rate at DRG | 43.02 |
| Home Discharge Rate with ICD G130 - Paraneoplastic neuromyopathy and neuropathy | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| VIBRA HOSPITAL OF LAKE TRAVIS LLC | 2000 MEDICAL DRIVE | LAKEWAY | TX | 78734 | 18 |
| MENORAH MEDICAL CENTER | 5721 W 119TH ST | OVERLAND PARK | KS | 66209 | 12 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JOHNNY SHANE ROSS | 2000 MEDICAL DR | LAKEWAY | TX | 78734 | 18 |